AstraZeneca wins two approval recommendations from EU agency

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York

(Reuters) - The European medicines watchdog has recommended approving AstraZeneca Plc's <AZN.L> treatments for a form of heart failure and a lung disorder, the British drugmaker said on Monday.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Forxiga for treating a form of heart failure and Trixeo Aerosphere for a form of lung disorder known as "smoker's lung".

(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Aditya Soni)